Perrigo (PRGO) Rx Price Erosion Appears To Creep Above Guided Range - Goldman Sachs
Tweet Send to a Friend
Goldman Sachs maintains Sell on Perrigo Co. (NYSE: PRGO) price target of $68.00.Analyst Jami Rubin writes to clients in a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
